CeGaT
CeGaT Receives CE Mark for Coronavirus Antibody Test
The test is designed to detect immunoglobulin G antibodies against the S1 domain of the SARS-CoV-2 spike protein in blood samples.
The company's assay relies on a set of 15 methylation and microRNA markers to determine whether a woman has breast cancer.
B. Braun China, CeGaT Collaborating on Clinical Genetic Testing Services in China
As part of the collaboration, B. Braun China founded a subsidiary, called B. Braun Precision Medicine Technology (BBPM), that opened in Shanghai in May.
The German company validated the panel, which focuses on actionable results, in a 300-participant clinical study in collaboration with Robert-Bosch-Hospital in Stuttgart.
German Genetic Dx Firm CeGaT Obtains CLIA Certification
With the new certification in hand, the company plans to expand its business in the US through its Pennsylvania-based subsidiary, B. Braun CeGaT.